Jefferies Financial Group Inc. United Therapeutics Corp Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$228.26 - $319.04 $981,518 - $1.37 Million	-4,300 Reduced 43.0%	5,700 $1.82 Million
Q1 2024 May 13, 2024	SELL	$210.76 - $249.51 $81,142 - $96,061	-385 Reduced 3.71%	10,000 $2.3 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $2.23 Million - $2.67 Million	10,385 New	10,385 $2.28 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $306,705 - $397,684	1,440 New	1,440 $322,000

672

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.